Chemotherapy of lung cancer: the experience of the National Cancer Institute of Milan.
D000230:Adenocarcinoma / Q000188:drug therapy; D001761:Bleomycin / Q000627:therapeutic use; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy* / Q000532:radiotherapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D004317:Doxorubicin / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage / Q000627:therapeutic use; D007558:Italy; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D008727:Methotrexate / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D012075:Remission, Spontaneous
D001761:Bleomycin; D011344:Procarbazine; D004317:Doxorubicin; D005472:Fluorouracil; D006918:Hydroxyurea; D008727:Methotrexate